About CRIS

The Consortium for Clinical Research and Innovation, Singapore (CRIS) was established in 2020 with the goal of strengthening synergies and developing strategies for national-level clinical research and translation programmes that are under the stewardship of the Ministry of Health. It is a subsidiary of MOH Holdings (MOHH).

About the Consortium for Clinical Research and Innovation, Singapore (CRIS)

CRIS brings together seven key national R&D initiatives and clinical services, and facilitate synergistic collaborations among them. These initiatives include:

• Singapore Clinical Research Institute (SCRI)

• National Health Innovation Centre Singapore (NHIC)

• Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)

• Precision Health Research, Singapore (PRECISE)

• Singapore Translational Cancer Consortium (STCC)

• Cardiovascular Disease National Collaborative Enterprise (CADENCE)

• Singapore Medical Foundation AI Model (SIMFONI)

CRIS aims to make a positive difference to Singapore patients and researchers by ensuring that these clinical research platforms and programmes are at the cutting edge of capability development and innovation. This will be achieved through facilitated collaborations and enduring partnerships with research and biomedical entities and communities across the public sector and industry across Singapore.

Our Vision

Excellence in Clinical and Translational Research for a Healthier Singapore

Our Mission

Advancing Capabilities and Collaborations through Innovative Research Programmes, to achieve Impactful Health and Economic Outcomes for Singapore

Our Values

Respect

• We recognise every employee as individuals with unique strengths.

• We create open and safe spaces for employees to grow and develop.

• We value diversity, inclusivity and fairness.

Integrity

• We strive to do the right thing.

• We ask for help when in difficult situations and hold ourselves accountable in our delivery.

Collaboration

• We are greater than the sum of parts.

• We trust each other to deliver on our respective areas of work.

• Trust and transparency are important foundations of our engagement.

• We share successes together.

Excellence

• We uphold the rules and standards we set in the company.

• Being in the clinical research field, we are willing to try and are open to experiment and innovate, to achieve the best outcomes.

• We adopt a growth mindset in everything we do, staying resilient and adaptable.